Member Info for ROCKZ

Posted my buy this morning, saw the post on here, received a reply from our friend CE and now the post has mysteriously disappeared.
I know some aren’t interested but some are so here we go again....2403 shares @ 82.7p

Cheers Shiraz, interesting material. I agree, credit to GC and KS for their vision here. They have purchased potentially top of the class drugs and then developed them to be administered in a novel form, orally or nasally. It could be looking like a stroke of genius very soon!

Ok CE, cheers for the advice again.

The share price for TILS, SNG, ODX etc has taken some heat. Just have to weather the storm and those that banked their Accustem shares should be thankful.
Oil stocks are now having a purple patch after being in the doldrums for quite a while.
Once the focus moves back on to treatment (which is necessary as the vaccine is not 100 per cent) this sector will start to move again.
The TILS share price has shown considerable strength in relation to its peers.

Weiner was super confident. He was just laughing with confidence and he’s the one who has studied Foralumab and knows it better than anyone.

I think Dr Weiner is the star of the show and if/when the time is right they need to let him take centre stage if the results are positive.
The man brings with him an element of Kudos and every time I see him speak it fills me with confidence.

The 70p estimate is all in my opinion by the way and just based upon what I see as a potential bottom if market sentiment went against the company.

I’m maxed out so won’t be buying anymore here for now but the risk/reward factor within 4 weeks is fantastic.
If the trial isn’t that positive we will obviously see a retrace. Worst case from this point bearing in mind we still have another COVID play, MS, Crohns, Alzheimer’s, and liver cancer is estimated at 70p. If the trial is a success however, I feel we will easily see the current SP doubled and possibly a return to the the £2.50 mark.

Another vaccine announcement on a Monday.
The Oxford/AstraZeneca vaccine is 70 per cent effective.
Not sure the results here are as good as expected.
This leaves a lot of demand for a suitable treatment still which potentially Tiziana have.

I don’t want to get carried away, the trial is still in progress and anything could happen but I would like to see a top media specialist on standby to really push this if the trial is a success.
It would be worth the investment from the BOD to really get the message out there through the major networks and they need to push the fact that the method of administration is so unique and basically a came changer aswell as being fully human.

It’s true that the big pharma companies tend to get the better media coverage, it’s the nature of the beast I suppose. I read somewhere that Trump had a financial interest in Regeneron at some point as registered on his tax return.

Hathaway advice is also to buy pharmaceutical at the moment.

Oh no, not that Swazers chap. Looks like a chancer to me. He tried dominating the HUR page some months ago with his chart predictions and the price just went lower and lower.
Part of the pump and dump crew, don’t want that here.

Agreed Tom, just added £7444, happy days.

No worries John. I am treating Accustem as profits locked away and will hold to see the company grow.
Tiziana looks in really good shape. Fully funded for the next 2 years. This should result in a more solid SP moving forward. Looking back at the RNS’s over the years the SP has been affected by placings.
The board have been diligent with their intellectual property, GC is heavily invested as the majority shareholder and I believe the company is being built ready for a takeover.
I’m not saying there won’t be more volatility over the next few weeks but moving forward I expect things to be absolutely fine.
I don’t think the Nomad did the company any favours with the way the demerger was delivered, it was a bit sketchy but time to move on from that, onwards and upwards.

The HC Wainwright valuation of StemprintER was in dollars- $280m.
$280m/190m shares= $1.47
$1.47 conversion to pounds = £1.11

This was a conservative valuation IMO from HC Wainwright compared to the OncotypeDX valuation of 2.8 billion.
The CEO has confirmed on the recent conference call that there is no current interest in Accustem from big pharma and they are looking to grow the company.
He reiterated that he does not want to sell it off on a cut price deal and wants to realise the potential.
So to summarise, those that brought in a few weeks or months ago and feel that they are underwater with TILS at the moment, you are not.
TILS and ACCUSTEM combined is over £2 so most are in a strong position and should relax.

It was a blessing that the main market RNS wasn’t released yesterday, it would have been lost within the vaccine news. I’d rather have some small daily rises for a few days whilst the dust settles and the markets realise this vaccine isn’t the silver bullet.

Woodstock1970 was only 4p short from his entry target lol!

So ok TILS dropped a bit today...we kind of expected the US might pull us down slightly so no big deal.
I’m assuming the value of Accustem has increased slightly due to the positive market sentiment.
I still expect a massive uplift if Brazil trials are positive

The MM’s have walked this down to flush out edgy investors and will continue to do so all the time people are selling.
You could tell from this board that people were edgy yesterday.
JUST HOLD and the MM’s will be forced to take the SP back up again, fairly simple.
I’m not selling a bean, this is a monster in the making.